Martin Zenke

Papers

Total Citations

H-Index

About

Martin Zenke is a leading figure in stem cell biology and bioengineering, whose work bridges the gap between fundamental stem cell research and scalable biomedical applications. His primary research areas include induced pluripotent stem cell (iPSC) technology, cellular reprogramming, and automated stem cell manufacturing. Zenke is best known for spearheading the development of the StemCellFactory, a pioneering modular robotic platform for the automated generation, expansion, and quality control of human iPSCs. This system, detailed in his highly cited 2020 paper (42 citations), addresses a critical bottleneck in the field: the high phenotypic variability among manually produced iPSC lines. By enabling parallelized, standardized production of large hiPSC cohorts, his work has significantly enhanced the reliability of disease modeling and genetic screening. Beyond this flagship achievement, Zenke’s research has profoundly impacted our understanding of hematopoietic stem cell differentiation and transcriptional regulation. With a career marked by over 15,000 citations, his contributions are foundational to the future of personalized medicine, providing the tools necessary to translate stem cell discoveries into robust, reproducible clinical and industrial applications.